Teva Pharmaceutical Industries Profit Margin 2006-2018 | TEVA

Current and historical gross margin, operating margin and net profit margin for Teva Pharmaceutical Industries (TEVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Teva Pharmaceutical Industries net profit margin as of December 31, 2018 is -11.4%.
Teva Pharmaceutical Industries Annual Profit Margins
Teva Pharmaceutical Industries Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $14.460B $18.854B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.576B 8.39
Mylan (MYL) United Kingdom $13.791B 5.84
Bausch Health Cos (BHC) Canada $8.063B 5.73
Dr Reddy's Laboratories (RDY) India $6.682B 26.65
Supernus Pharmaceuticals (SUPN) United States $1.834B 17.02
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.598B 2.60
Amphastar Pharmaceuticals (AMPH) United States $0.932B 86.61
Homology Medicines (FIXX) United States $0.855B 0.00
CymaBay Therapeutics (CBAY) United States $0.720B 0.00
Voyager Therapeutics (VYGR) United States $0.630B 0.00
Assembly Biosciences (ASMB) United States $0.411B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.411B 0.00
Akorn (AKRX) United States $0.367B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.176B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.173B 0.00
Sol-Gel Technologies (SLGL) Israel $0.135B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Agile Therapeutics (AGRX) United States $0.061B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Teligent (TLGT) United States $0.046B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.013B 0.00